Morgan Stanley
PLXP

Morgan Stanley’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Morgan Stanley’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-179,616
Closed -$23.4K – 7825
2023
Q1 		$23.4K Sell
179,616
-10,197
-5% -$2.07K ﹤0.01% 6568
2022
Q4 		$31.1K Sell
189,813
-44,291
-19% -$18.5K ﹤0.01% 6499
2022
Q3 		$152K Sell
234,104
-436,906
-65% -$644K ﹤0.01% 5869
2022
Q2 		$1.63M Sell
671,010
-183,733
-21% -$510K ﹤0.01% 4688
2022
Q1 		$3.45M Sell
854,743
-3,749
-0.4% -$20.6K ﹤0.01% 4063
2021
Q4 		$6.88M Buy
858,492
+646,659
+305% +$7.58M ﹤0.01% 3377
2021
Q3 		$4.09M Buy
211,833
+129,229
+156% +$2.26M ﹤0.01% 3945
2021
Q2 		$1.14M Buy
82,604
+82,227
+21,811% +$974K ﹤0.01% 5006
2021
Q1 		$3K Buy
377
+127
+51% +$928 ﹤0.01% 7236
2020
Q4 		$1K Hold
250
– – ﹤0.01% 6991
2020
Q3 		$1K Hold
250
– – ﹤0.01% 6693
2020
Q2 		$1K Hold
250
– – ﹤0.01% 6547
2020
Q1 		$1K Hold
250
– – ﹤0.01% 6511
2019
Q4 		$1K Sell
250
-243
-49% -$1.14K ﹤0.01% 6609
2019
Q3 		$2K Buy
493
+205
+71% +$1.19K ﹤0.01% 6504
2019
Q2 		$2K Buy
288
+38
+15% +$206 ﹤0.01% 6488
2019
Q1 		$1K Hold
250
– – ﹤0.01% 6549
2018
Q4 		$0 Hold
250
– – ﹤0.01% 6797
2018
Q3 		$1K Sell
250
-132
-35% -$497 ﹤0.01% 6675
2018
Q2 		$1K Hold
382
– – ﹤0.01% 6623
2018
Q1 		$1K Sell
382
-70
-15% -$443 ﹤0.01% 6565
2017
Q4 		$3K Sell
452
-18
-4% -$125 ﹤0.01% 6417
2017
Q3 		$3K Sell
470
-76
-14% -$488 ﹤0.01% 6375
2017
Q2 		$3K Buy
546
+73
+15% +$534 ﹤0.01% 6428
2017
Q1 		$5K Sell
473
-30
-6% -$326 ﹤0.01% 6364
2016
Q4 		$6K Sell
503
-166
-25% -$6.1K ﹤0.01% 6257
2016
Q3 		$77K Buy
669
+1
+0.1% +$98 ﹤0.01% 5415
2016
Q2 		$53K Sell
668
-9
-1% -$780 ﹤0.01% 5513
2016
Q1 		$51K Sell
677
-583
-46% -$37.1K ﹤0.01% 5606
2015
Q4 		$112K Sell
1,260
-1,075
-46% -$103K ﹤0.01% 5347
2015
Q3 		$261K Buy
2,335
+1,387
+146% +$160K ﹤0.01% 4961
2015
Q2 		$96K Buy
948
+488
+106% +$50.5K ﹤0.01% 5611
2015
Q1 		$50K Buy
460
+321
+231% +$32.9K ﹤0.01% 5797
2014
Q4 		$13K Buy
139
+64
+85% +$5.46K ﹤0.01% 6162
2014
Q3 		$6K Buy
75
+44
+142% +$3.36K ﹤0.01% 6305
2014
Q2 		$2K Sell
31
-3,958
-99% -$308K ﹤0.01% 6400
2014
Q1 		$322K Buy
+3,989
New +$366K ﹤0.01% 4848

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Morgan Stanley's PLXP Position: Q2 2023 in Review

Morgan Stanley sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 179,616 shares — an estimated $23.4K sold.

Morgan Stanley first reported a position in PLXP in Q1 2014 and held it in 37 quarters. The position peaked at $6.88M in Q4 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Morgan Stanley reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 179,616 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $23.4K.
  • Morgan Stanley first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 37 quarters.
  • Morgan Stanley's PLx Pharma Inc. Common Stock position peaked at $6.88M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.